⌘K

Login Start Free

Home/Filings/4/0001012975-25-000812

4//SEC Filing

Banks Jerel A. 4

Accession 0001012975-25-000812

CIK 0001808898other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:36 PM ET

Size

5.2 KB

Accession

0001012975-25-000812

Insider Transaction Report

Form 4

Period: 2025-11-18

Benitec Biopharma Inc.BNTC

DirectorChief Executive Officer

Transactions

Award
Options (right to buy)
2025-11-18+450,000→ 450,000 total
Exercise: $13.53Exp: 2035-11-18→ Common Stock (450,000 underlying)

Footnotes (1)

[F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother

Related Parties

1

filerCIK 0001808930

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 5:36 PM ET
Size: 5.2 KB

View on SEC.gov